Drugs / G-CSF
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00733824 Background | Nov 2008 → Sep 2012 | Hodgkins lymphoma, non-Hodgkin lymphoma | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00733824 ↗ |
| Route | Subcutaneous | “10 µg/kg SC G-CSF Day -4 thru Day -1” NCT00733824 ↗ |